Tennessee Oncology Nashville Midtown — Nashville, Tennessee

Tennessee Oncology Nashville Midtown is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Tennessee Oncology Nashville Midtown has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Gastric Cancer, Gastroesophageal Junction Cancer.

Sponsors: Daiichi Sankyo.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology Nashville Midtown?

Tennessee Oncology Nashville Midtown has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology Nashville Midtown conducted?

Tennessee Oncology Nashville Midtown has 1 clinical trials on record, with 1 currently active. Their work covers Gastric Cancer, Gastroesophageal Junction Cancer.

Is Tennessee Oncology Nashville Midtown accredited by Crixeo Health?

Tennessee Oncology Nashville Midtown has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology Nashville Midtown?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.